What Is the Collateral Source Rule in Personal Injury?

James Wong — Founder & Pharmacist, LienScripts | February 17, 2026 | 8 min read

The collateral source rule prevents defendants from reducing a plaintiff's damages because the plaintiff received benefits from an independent third party. Here's how it protects pharmacy lien patients.

The Collateral Source Rule Explained

When you are injured in an accident caused by someone else's negligence, you deserve to be made whole. But what happens when your health insurance, a government program, or a pharmacy lien provider covers some of your medical expenses while your case is pending? Does the at-fault party get credit for those payments and owe you less?

The answer, under the collateral source rule, is no.

The collateral source rule is a long-standing common law doctrine that bars a defendant from reducing the damages owed to an injured plaintiff simply because the plaintiff received compensation or benefits from a source independent of the defendant. If a third party — your insurer, a government program, or a lien-based provider — pays for some or all of your treatment, the defendant cannot point to those payments and argue they should subtract that amount from the judgment or settlement.

The rule exists because allowing defendants to benefit from a plaintiff's foresight in obtaining insurance or other benefits would be fundamentally unjust. The plaintiff paid premiums, accepted a lien obligation, or otherwise arranged independent coverage. The wrongdoer should not get a windfall from the plaintiff's prudence.

Why the Collateral Source Rule Matters for Pharmacy Liens

Pharmacy lien programs occupy a critical space in personal injury treatment. When an injured patient has no insurance, has insurance that excludes injury-related prescriptions, or simply cannot afford out-of-pocket medications while waiting for their case to resolve, a pharmacy lien provider steps in. The pharmacy fills the prescriptions now and is repaid from the eventual settlement or judgment.

[!KEY] Because pharmacy lien payments come from a source entirely independent of the defendant, they are a textbook collateral source benefit. The defendant's insurer cannot reduce the damages demand or settlement offer by pointing to the pharmacy lien payments already made on the patient's behalf.

This matters enormously in demand packages. When an attorney assembles the full picture of a client's damages, the pharmacy lien balance is a legitimate line item. The defense cannot argue that those medications were "already paid for" in a way that diminishes the claim. The defendant owes the full value of the harm caused, regardless of how that harm was financed in the interim.

The Original Policy Rationale

Courts have justified the collateral source rule on multiple grounds over the decades:

Deterrence. Allowing defendants to escape full liability would reduce the incentive for potential tortfeasors to exercise reasonable care. If a negligent driver knew that the victim's health insurance would absorb most of the damage, the driver's effective liability would be artificially reduced.

Unjust enrichment. A defendant who injures someone should not profit from the plaintiff's independent arrangements. The plaintiff — not the wrongdoer — should capture the benefit of having obtained third-party coverage.

Proportionality. The goal of tort damages is to make the plaintiff whole, not to enrich the defendant. Full compensation requires that the plaintiff recover the reasonable value of services rendered, even if a third party fronted the cost.

[!SOURCE] Helfend v. Southern California Rapid Transit District, 2 Cal.3d 1 (1970) — the leading California Supreme Court case that solidified the collateral source rule and articulated the unjust-enrichment rationale in detail.

How the Rule Applies in Practice: A Pharmacy Lien Scenario

Consider a patient injured in a rear-end collision in California. The at-fault driver's insurer is State Farm. The patient has no health insurance that covers injury-related prescriptions, so their attorney refers them to a pharmacy lien provider. Over eight months of treatment, the patient receives muscle relaxants, topical anti-inflammatories, and a compound pain cream, all on lien.

When the demand package is assembled, the pharmacy lien balance appears as part of the special damages. State Farm's adjuster cannot respond: "We see the pharmacy was paid — we're deducting that from our offer." The collateral source rule bars that argument. The lien was created through an independent commercial arrangement between the patient and the pharmacy lien provider. The defendant owes the full reasonable value of the medications prescribed.

In practice, the lien is satisfied at settlement from the plaintiff's recovery. But the legal principle is that the defendant's liability is measured by the harm caused, not reduced by the plaintiff's independent financing arrangements.

State-by-State Variation

While the collateral source rule is recognized in all U.S. jurisdictions, states differ significantly in how they apply it — and some states have modified or partially abrogated it through tort reform legislation.

California maintains a robust collateral source rule with some nuance. Under Howell v. Hamilton Meats (2011), the rule applies to the reasonable value of services, but defendants may argue that the plaintiff's actual out-of-pocket exposure was limited. This creates tension in high-lien cases and is an active area of litigation. For pharmacy liens, the lien amount itself represents a real obligation the plaintiff bears, so it generally survives Howell scrutiny.

Florida codified a modified collateral source rule under Florida Statute § 768.76. Courts reduce economic damages by certain collateral source payments, with exceptions for amounts the plaintiff must repay (i.e., liens). Because a pharmacy lien creates a genuine repayment obligation, lien balances are typically not subject to the Florida offset.

Texas follows a reasonable and necessary standard. The collateral source rule applies, but damages are limited to the amount actually paid or incurred, not the full billed amount. Texas pharmacy lien cases require careful documentation of the incurred obligation.

New York applies the collateral source rule broadly. Defendants may not offset settlements by payments from collateral sources, and pharmacy lien obligations are treated as genuine damages.

Nevada preserves the collateral source rule in personal injury cases. Nevada attorneys frequently use pharmacy liens for uninsured and underinsured clients, and the rule protects the full lien value as compensable damages.

[!KEY] The key in every state is documenting the lien as a real, enforceable obligation — not a gratuity. A signed lien agreement, a formal assignment of benefits, and detailed prescription records all establish that the pharmacy lien is a legitimate debt the plaintiff owes, placing it squarely within collateral source protection.

The Subrogation Overlap

One nuance that attorneys must understand: the collateral source rule does not eliminate subrogation rights. When a health insurer pays for treatment, it may have a subrogation claim against the settlement proceeds. Similarly, certain government programs (Medicare, Medicaid) have statutory reimbursement rights.

Pharmacy liens are different from subrogation claims in an important way. A subrogating insurer steps into the plaintiff's shoes to recover what it paid. A pharmacy lien provider, by contrast, has not yet been paid — the lien is an unpaid obligation secured by the future settlement. The collateral source rule prevents the defendant from reducing the gross damages; the lien is then satisfied from the plaintiff's net recovery.

This means the plaintiff and their attorney must account for both sides: the collateral source rule maximizes the gross recovery, and then lien resolution (through negotiation or statutory reduction where applicable) maximizes the net recovery.

[!SOURCE] Restatement (Second) of Torts § 920A (1979) — the foundational secondary authority distinguishing collateral source payments from payments by the tortfeasor, and addressing the subrogation overlay.

Practical Guidance for Attorneys

When building a demand package that includes pharmacy lien medications:

1. Include the full lien balance as special damages. The defendant is liable for the reasonable value of all medications prescribed as a result of the injury.

2. Attach the lien agreement and itemized prescription records. This establishes the lien as a real, documented obligation — not a speculative or inflated figure.

3. Be prepared to address Howell-type challenges in California. If defense counsel argues the reasonable value is less than the lien amount, have the pharmacy's customary rates and documentation ready.

4. Account for post-MMI medications. Even after a defense IME declares maximum medical improvement, the plaintiff may remain on a maintenance medication regimen. Those ongoing lien obligations are compensable damages.

5. Know your state's tort reform modifications. In modified collateral source states like Florida and Colorado, confirm that the lien creates a genuine repayment obligation that survives any statutory offset analysis.

The collateral source rule is one of the foundational protections for injured plaintiffs. When combined with a well-documented pharmacy lien, it ensures that the defendant pays the full value of the medication-related harm they caused — regardless of how the plaintiff financed their treatment while the case was pending.

Related Resources

• What Is a Pharmacy Lien? A Complete Guide
• What Is Lien Reduction in Personal Injury?
• Health Insurance Subrogation vs. Pharmacy Lien
• What Is Assignment of Benefits in Personal Injury?